Artivion Balance Sheet Health
Financial Health criteria checks 6/6
Artivion has a total shareholder equity of $438.7M and total debt of $214.9M, which brings its debt-to-equity ratio to 49%. Its total assets and total liabilities are $857.7M and $419.0M respectively. Artivion's EBIT is $25.9M making its interest coverage ratio 0.9. It has cash and short-term investments of $73.4M.
Key information
48.98%
Debt to equity ratio
US$214.87m
Debt
| Interest coverage ratio | 0.9x |
| Cash | US$73.43m |
| Equity | US$438.69m |
| Total liabilities | US$418.97m |
| Total assets | US$857.66m |
Recent financial health updates
Is Artivion (NYSE:AORT) Using Too Much Debt?
Jul 10
Here's Why Artivion (NYSE:AORT) Has A Meaningful Debt Burden
Apr 08Is Artivion (NYSE:AORT) A Risky Investment?
Jun 28Is Artivion (NYSE:AORT) Using Too Much Debt?
Jan 13Recent updates
Artivion (NYSE:AORT) Might Have The Makings Of A Multi-Bagger
Sep 11Share Growth And Strong Clinical Results Continue To Support The Artivion Story
Sep 03Revenues Tell The Story For Artivion, Inc. (NYSE:AORT) As Its Stock Soars 37%
Aug 12Is Artivion (NYSE:AORT) Using Too Much Debt?
Jul 10
Global Heart Valve Demand Will Expand Future Markets
Advances in medical technology, strong clinical evidence, and new product launches are expanding Artivion's market opportunities and enabling premium pricing for top-line growth.Artivion, Inc.'s (NYSE:AORT) 29% Jump Shows Its Popularity With Investors
May 09Artivion, Inc.'s (NYSE:AORT) CEO Looks Like They Deserve Their Pay Packet
May 06Here's Why Artivion (NYSE:AORT) Has A Meaningful Debt Burden
Apr 08Artivion, Inc. Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next
Feb 27Is Now An Opportune Moment To Examine Artivion, Inc. (NYSE:AORT)?
Feb 13Why Investors Shouldn't Be Surprised By Artivion, Inc.'s (NYSE:AORT) P/S
Jan 09Artivion: Current Valuation Seems Stretched.
Dec 26Estimating The Fair Value Of Artivion, Inc. (NYSE:AORT)
Dec 19When Should You Buy Artivion, Inc. (NYSE:AORT)?
Nov 07Returns At Artivion (NYSE:AORT) Are On The Way Up
Sep 28Estimating The Intrinsic Value Of Artivion, Inc. (NYSE:AORT)
Sep 06Is Artivion (NYSE:AORT) A Risky Investment?
Jun 28Data-Driven Growth Fuels More Upside For Overlooked Artivion
Jun 21Artivion's (NYSE:AORT) Returns On Capital Are Heading Higher
May 08Is Artivion (NYSE:AORT) Using Too Much Debt?
Jan 13Artivion Stock: A First Assessment
Dec 27Investors Still Aren't Entirely Convinced By Artivion, Inc.'s (NYSE:AORT) Revenues Despite 27% Price Jump
Nov 23Financial Position Analysis
Short Term Liabilities: AORT's short term assets ($337.5M) exceed its short term liabilities ($85.8M).
Long Term Liabilities: AORT's short term assets ($337.5M) exceed its long term liabilities ($333.1M).
Debt to Equity History and Analysis
Debt Level: AORT's net debt to equity ratio (32.2%) is considered satisfactory.
Reducing Debt: AORT's debt to equity ratio has reduced from 89.3% to 49% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable AORT has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: AORT is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 7% per year.
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/04 15:52 |
| End of Day Share Price | 2025/12/04 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Artivion, Inc. is covered by 14 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Raymond Myers | Benchmark Company |
| William Plovanic | Canaccord Genuity |
| David Turkaly | Citizens JMP Securities, LLC |